Full name
PAUL HARTMANN MANUFACTURING SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
32.50.Z - Production of medical devices, instruments, and products, including dental products
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Assets | 79,8 | 0,2 | 0,3 | 55,3 |
Gross profit (loss) | -1,1 | 0 | -0 | -189,9 |
EBITDA | -1,1 | 0 | 0 | 74,3 |
Net profit (loss) | -1,1 | 0 | -0 | -200,7 |
Cash | 17,7 | 0 | 0 | 94,2 |
Liabilities and provisions for liabilities | 29,4 | 0 | 0,1 | 90,9 |
Net income from sale | 0 | 0 | 0 | -∞ |
Short time liabilities | 29,4 | 0 | 0,1 | 95,7 |
Working assets | 26,7 | 0 | 0,1 | 101,1 |
Equity capital | 50,4 | 0,2 | 0,3 | 48,3 |
Operating profit (EBIT) | -1,1 | 0 | 0 | -93,6 |
Depreciation | 0 | 0 | 0 | 456,2 |
% | % | % | p.p. | |
Profitability of capital | -2,2 | 0,6 | -0,4 | -1 |
Equity capital to total assets | 63,1 | 83,5 | 79,7 | -3,8 |
Gross profit margin | -29,7 | |||
EBITDA Margin | 105,1 | |||
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 5410 | -2 147 478 238 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane